Relationship Between Lymphocyte Count and Risk Of Infection In Rheumatoid Arthritis Patients Treated With Tofacitinib

被引：0
作者：
Van Vollenhoven, R. F. [1 ]
Riese, R. [2 ]
Krishnaswami, S. [2 ]
Kawabata, T. [2 ]
Fosser, C. [2 ]
Rottinghaus, S. [2 ]
Lamba, M. [2 ]
Zwillich, S. H. [2 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Pfizer Inc, Groton, CT 06340 USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2330
引用
收藏
页码：S994 / S994
页数：1
相关论文
共 50 条
  • [21] Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate
    Saito, Shuntaro
    Kaneko, Yuko
    Yamaoka, Kunihiro
    Tokuhira, Michihide
    Takeuchi, Tsutomu
    RHEUMATOLOGY, 2017, 56 (06) : 940 - 946
  • [22] Reduction in Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk in Patients Treated with Tofacitinib
    Baker, Matthew
    Liu, Yuhan
    Lu, Rong
    Lin, Janice
    Melehani, Jason
    Robinson, William
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4476 - 4478
  • [23] Malignancy Data in Tofacitinib-Treated Japanese Patients with Rheumatoid Arthritis
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Sugiyama, Naonobu
    Yoshinaga, Takunari
    Togo, Kanae
    Geier, Jamie
    Boy, Mary
    Connell, Carol
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [24] MALIGNANCY DATA IN TOFACITINIB-TREATED JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS
    Tanaka, Y.
    Takeuchi, T.
    Yamanaka, H.
    Sugiyama, N.
    Yoshinaga, T.
    Togo, K.
    Geier, J.
    Boy, M.
    Connell, C. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 263 - 263
  • [25] TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS - THE RESULTS OF RUSSIAN NATIONAL REGISTER OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB
    Gaydukova, Inna
    Mazurov, V.
    Zhilyaev, Evgeniy
    Grabovetskaya, Iuliia
    Marusenko, Irina
    Vasilenko, Elizaveta
    Abdulganieva, Diana
    Smitienko, Ilia
    Misiyuk, Anna
    Lukina, Galina
    Knyazeva, Larisa
    Kalinina, Elena
    Samigullina, Ruzana
    Bondareva, Irina
    Yudina, Natalya
    Lapkina, N.
    Nasonov, Evgeny
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 359 - 360
  • [26] MALIGNANCIES RISK IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB OR TNF INHIBITORS, A NATIONAL STUDY: RELATION STUDY
    Gottenberg, J. E.
    Kessouri, M.
    Rudant, J.
    Assi, N.
    Raguideau, F.
    Kirchgesner, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 713 - 714
  • [27] Malignancies Risk in Rheumatoid Arthritis Patients Treated with Tofacitinib or TNF Inhibitors, a National Study: RELATION Study
    Gottenberg, Jacques-eric
    Mammar, Nadir
    Kessouri, Meriem
    Rudant, Jeremie
    Assi, Nada
    Raguideau, Fanny
    Kirchgesner, Julien
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3913 - 3916
  • [28] Risk for Herpes Zoster in Tofacitinib-Treated Rheumatoid Arthritis Patients With and Without Concomitant Methotrexate and Glucocorticoids
    Curtis, Jeffrey R.
    Xie, Fenglong
    Yang, Shuo
    Bernatsky, Sasha
    Chen, Lang
    Yun, Huifeng
    Winthrop, Kevin
    ARTHRITIS CARE & RESEARCH, 2019, 71 (09) : 1249 - 1254
  • [29] Infection in Rheumatoid Arthritis Patients Treated with Golimumab
    Bessette, Louis
    Rahman, Proton
    Kelsall, John
    Purvis, Jane
    Rampakakis, Emmanouil
    Lehman, Allen
    Rachich, Meagan
    Nantel, Francois
    Asin-Milan, Odalis
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1646 - 1647
  • [30] CHANGES IN LYMPHOCYTES AND LYMPHOCYTE SUBSETS IN TOFACITINIB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS
    Burmester, G.
    Rigby, W. F. C.
    Choy, E.
    Nash, P.
    Winthrop, K.
    Mease, P. J.
    Young, P.
    Hendrikx, T.
    Wang, C.
    Menon, S.
    Graham, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1030 - 1030
12345